Ethnicity and use of alternative products in psychiatric patients

Psychosomatics

Volumn 47, Issue 5, 2006, Pages 408-413

  Ng, Bernardo ^a,b   Camacho, Alvaro ^a   Simmons, Alan ^a   Matthews, Scott C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Sun Valley Behavioral Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; NATURAL PRODUCT;

ALTERNATIVE MEDICINE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNICITY; GARLIC; GINKGO BILOBA; GINSENG; HEALTH CARE PERSONNEL; HERBAL MEDICINE; HISPANIC; HUMAN; HYPERICUM PERFORATUM; MAJOR CLINICAL STUDY; MENTAL DISEASE; MENTAL PATIENT; ETHNIC GROUP; OUTPATIENT; PHYTOTHERAPY; PSYCHOLOGICAL ASPECT; RURAL POPULATION; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

CALIFORNIA; COMPLEMENTARY THERAPIES; ETHNIC GROUPS; HUMANS; MENTAL DISORDERS; OUTPATIENTS; PHYTOTHERAPY; RURAL POPULATION;

EID: 33749243117     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.47.5.408     Document Type: Article

References (49)

1. Hao W, Zhao M: A comparative clinical study of the effect of WeiniCom, a Chinese herbal compound, on alleviation treatment. J Psychoactive Drugs 2000; 32:277-284
2. Zahourek R: Alternative, complementary, or integrative approaches to treating depression. Journal of the American Psychiatric Nurses Association 2000; 6:77-86
3. Chen C-H, Voiding DC: Medicinal foods: cross-cultural perspectives. Drug Society 1999; 15(l-2):49-64
4. Zenk SN, Shaver JL, Peragallo N, et al: Use of herbal therapies among midlife Mexican women. Health Care Women Int 2001; 22:585-597
5. Astin JA, Pelletier KR, Marie A, et al: Complementary and alternative medicine use among elderly persons: one-year analysis of a Blue Shield Medicare supplier. J Gerontol 2000; 55A:M4-M9
6. Dello BM, Urciuoli O, Marietta P, et al: Alternative medicine in a sample of 655 community-dwelling elderly. J Psychosom Res 2001; 50:147-154
7. Foster DF, Phillips RS, Hamel MB, et al: Alternative medicine use in older Americans. J Am Geriatr Soc 2001; 48:1560-1565
8. Ni H, Simile C, Hardy AM: Utilization of complementary and alternative medicine by United States adults: results from the 1999 National Health Interview survey. Med Care 2002; 40:353-358
9. Brown RP, Gerbarg PL: Herbs and nutrients in the treatment of depression, anxiety, insomnia, migraine, and obesity. Journal of Psychiatric Practice 2001; 7:75-91
10. Kasper S, Dienel A: Cluster analysis of symptoms during antidepressant treatment with hypericum extract in mildly-to-moderately depressed outpatients: a meta-analysis of data from three randomized, placebo-controlled trials. Psychopharmacology (Berl) 2002; 164:301-308
11. Laakmann G, Jahn G, Schuele C: Hypericum perforatum extracts in the treatment of mild-to-moderate depression: clinical and pharmacological aspects. Nervenartzt 2002; 73:600-612
12. Schuele C, Baghai T, Ferrera A, et al: Neuroendocrine effects of hypericum extract WS 5570 in 12 healthy male volunteers. Pharmacopsychiatry 2001; 34(suppl 11):S127-S133
13. Whiskey E, Werneke U, Taylor D: A systematic review and meta-analysis of Hypericum perforamm in depression: a comprehensive clinical review. Int Clin Psychopharmacol 2001; 16:239-252
14. Beaubrun G, Gray GE: A review of herbal medicines for psychiatric disorders. Psychiatr Serv 2000; 51:1130-1134
15. Werneke U, Earl J, Seydel C, et al: Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer 2004; 90:408-413
16. Galluzzi S, Zanetti O, Binetti G, et al: Coma in a patient with Alzheimer's disease taking low-dose trazodone and ginkgo biloba. J Neurol Neurosurg Psychiatry 2000; 68:679-680
17. Campo JV, McNabb J, Perel JM, et al: Kava-induced fulminant hepatic failure. J Am Acad Child Adoles Psychiatr 2002; 41:631-632
18. Escher M, Desmeules J, Giostra E, et al: Hepatitis associated with kava, an herbal remedy for anxiety. BMJ 2001; 322:1097;
19. erratum: BMJ 2001; 322:1097
20. Loera JA, Black SA, Markides KS, et al: The use of herbal medicine by older Mexican Americans. J Gerontol Biol Med Sci 2001; 56A:M714-M718
21. Hunt LM, Arar NH, Akana LL: Herbs, prayer, and insulin: use of medical and alternative treatments by a group of Mexican American diabetes patients. J Fam Pract 2000; 49:216-223
22. Chen X, Wu T, Liu G, et al: Chinese medicinal herbs for influenza. Cochrane Database Syst Rev 2005; 25(1):CD004559
23. Hailemaskel B, Dutta A, Wutoh A: Adverse reactions and interactions among herbal users. Issues in Interdisciplinary Care 2001; 3:297-300
24. Walach H, Rilling C, Engelke U: Efficacy of Bach-flower remedies in test anxiety: a double-blind, placebo-controlled, randomized trial with partial crossover. J Anxiety Disord 2001; 15:359-366
25. Bradwejn JC, Zhou Y, Koszycki D, et al: A double-blind, placebo-controlled study on the effects of Gotu kola (Centella asiatica) on acoustic startle response in healthy subjects. J Clin Psychopharmacol 2000; 20:680-684
26. Watkins LL, Connor KM, Davidson JR: Effect of kava extract on vagal cardiac control in generalized anxiety disorder: preliminary findings. J Psychopharmacol 2001; 15:283-286
27. Connor KM, Davidson JR: A placebo-controlled study of Kava kava in generalized anxiety disorder. Int Clin Psychopharmacol 2002; 17:185-188
28. Malsch U, Kieser M: Efficacy of kava kava in the treatment of nonpsychotic anxiety, following pretreatment with benzodiazepines. Psychopharmacology 2001; 157:277-283
29. Hypericum Depression Trial Study Group: Effect of Hypericum perforatum (St. John's wort) in major depressive disorder: a randomized, controlled trial. JAMA 2002; 287:1804-1814
30. Shelton RC, Keller MB, Gelenberg A, et al: Effectiveness of St. John's wort in major depression: a randomized, controlled trial. JAMA 2001; 285:1978-1986
31. Kalb R, Trautmann-Sponsel RD, Kieser M: Efficacy and toler-ability of hypericum extract (WS 5572) versus placebo in mildly-to-moderately depressed patients: a randomized, double-blind, multicenter clinical trial. Pharmacopsychiatry 2001; 34:96-103
32. Friede M, Henneicke von Zepelin HH, Freudenstein J: Differential theory of mild-to-moderate depressive episodes (ICD-10 F32.0; F32.1) with St. John's wort. Pharmacopsychiatry 2001; 34(suppl1): S38-S41
33. Kaufeler R, Meier B, Brattstrom A: Efficacy and tolerability of (Ze-117) St. John's wort extract compared with placebo, imipramine, and fluoxetine for the treatment of mild-to-moderate depression according to ICD-10: an overview. Pharmacopsychiatry 2001; 34(suppll):S49-S50
34. Lecmbier Y, Clerc G, Didi R, et al: Efficacy of St. John's wort extract (WS 5570) in major depression: a double-blind, placebo-controlled trial. Am J Psychiatry 2002; 159:1361-1366
35. Kennedy DO, Scholey AB, Tildesley NT, et al: Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav 2002; 72:953-964
36. Zhang XY, Zhou DF, Zhang PY, et al: A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia. J Clin Psychiatry 2001; 62:878-883
37. Schellenberg R: Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo-controlled study. BMJ 2001; 322:134-137
38. Volz HP, Murck H, Kasper S, et al: St. John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial. Psychopharmacology (Berl) 2002; 164:294-300
39. Winther K, Rein E, Hedman C: Femal: an herbal remedy made from pollen extracts, reduces hot flashes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study. Climacteric 2005; 8:162-170
40. Roodenrys S, Booth D, Bulzomi S, et al: Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology 2002; 27:279-281
41. Maher BF, Stough C, Shelmerdine A, et al: The acute effects of combined administration of Ginkgo biloba and Bacopa monniera on cognitive function in humans. Hum Psychopharmacol 2002: 17:163-164
42. Solomon PR, Adams F, Silver A, et al: Ginkgo for memory enhancement: a randomized, controlled trial. JAMA 2002; 288:835-840
43. Le Bars PL, Velasco FM, Ferguson JM, et al: Influence of the severity of cognitive impairment on the effect of the Ginkgo biloba extract (EGb 761) in Alzheimer's disease. Neuropsychobiology 2002; 45:19-26
44. van Dongen MC, van Rossum E, Kessels AG, et al: The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial. J Am Geriatr Soc 2000; 48:1183-1194
45. Kennedy DO, Scholey AB, Wesnes KA: The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology (Berl) 2000; 151:416-423
46. Moulton PL, Boyko LN, Fitzpatrick JL, et al: The effect of Ginkgo biloba on memory in healthy male volunteers. Physiol Behav 2001; 73:659-665
47. Scholey AB, Kennedy DO: Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng, and their combination in healthy young volunteers: differential interactions with cognitive demand. Hum Psychopharmacol 2002; 17:35-44 47. Timoshanko A, Stough C, Vitetta L, et al: A preliminary investigation on the acute pharmacodynamic effects of hypericum on cognitive and psychomotor performance. Behav Pharmacol 2001; 12: 635-640
48. Holmes C, Hopkins V, Hensford C, et al: Lavender oil as a treatment for agitated behavior in severe dementia: a placebo-controlled study. Int J Geriatr Psychiatry 2002; 17:305-308
49. Ballard CG, O'Brien JT, Reichelt K, et al: Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled, trial with Melissa. J Clin Psychiatry 2002; 63:553-558